A PHASE 2 OPEN LABEL STUDY TO INVESTIGATE THE EFFICACY OF AUTOLOGOUS EBV-SPECIFIC T-CELLS FOR THE TREATMENT OF PATIENTS WITH AGGRESSIVE EXTRANODAL NK/T CELL LYMPHOMA (ENKTCL) - Regional Cancer Care Associates LLC

Clinical Trials

A PHASE 2 OPEN LABEL STUDY TO INVESTIGATE THE EFFICACY OF AUTOLOGOUS EBV-SPECIFIC T-CELLS FOR THE TREATMENT OF PATIENTS WITH AGGRESSIVE EXTRANODAL NK/T CELL LYMPHOMA (ENKTCL)

Type of Cancer
Lymphoma
Locations
Hackensack
Sponsor
Cell Medica
Protocol Number
CM-2013-01
Cancer Diagnosis
To Learn More Call
201-510-0910